Clinical Trial Update: Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating the effectiveness of Detrusitol in patients with urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence

Drugs mentioned

• Detrusitol (tolterodine)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Urinary Incontinence | Phase 4 | Status: COMPLETED